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Abstract
Background: Connectivity mapping is a process to recognize novel pharmacological and
toxicological properties in small molecules by comparing their gene expression signatures with
others in a database. A simple and robust method for connectivity mapping with increased
specificity and sensitivity was recently developed, and its utility demonstrated using experimentally
derived gene signatures.
Results: This paper introduces sscMap (statistically significant connections' map), a Java application
designed to undertake connectivity mapping tasks using the recently published method. The
software is bundled with a default collection of reference gene-expression profiles based on the
publicly available dataset from the Broad Institute Connectivity Map 02, which includes data from
over 7000 Affymetrix microarrays, for over 1000 small-molecule compounds, and 6100 treatment
instances in 5 human cell lines. In addition, the application allows users to add their custom
collections of reference profiles and is applicable to a wide range of other 'omics technologies.
Conclusion: The utility of sscMap is two fold. First, it serves to make statistically significant
connections between a user-supplied gene signature and the 6100 core reference profiles based on
the Broad Institute expanded dataset. Second, it allows users to apply the same improved method
to custom-built reference profiles which can be added to the database for future referencing. The
software can be freely downloaded from http://purl.oclc.org/NET/sscMap.
Background
Interaction of a drug or chemical with a biological system
can result in a gene-expression profile or signature charac-
teristic of the event. Lamb et al were the first to propose
using these data in connectivity mapping to make connec-
tions between the pharmacological and toxicological
properties of small molecules [1]. The three key compo-
nents in the working of a connectivity map are: 1) a col-
lection of pre-built reference gene-expression profiles that
serves as a core database; 2) a query gene signature, usu-
ally prepared by the user, which best characterizes a com-
pound-induced biological state and; 3) a similarity metric
to quantify the connection between a gene signature and
a reference profile. In a previous publication [2] we pre-
sented a simple and robust method for connecting small-
molecule drugs using gene-expression signatures, the util-
ity of which was shown using three experimentally
derived gene signatures from independent studies for
HDAC inhibitors [3], estrogen [4], and immunosuppres-
sive drugs [5], respectively. Here in this paper we describe
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and we focus on its utility and extensibility from a user's
perspective.
Implementation
The software was built using Java programming language
(Java Platform, Standard Edition 6). JFC/Swing classes
were used to provide a Graphical User Interface (GUI) of
the program. In designing the software, user extensibility
was considered to be an important feature. To this end
each individual reference profile is stored as a separate file
on the disk. This setting greatly enhances flexibility and
extensibility of the software, as it allows users to supple-
ment the default collection of reference profiles, or to
build custom collection of reference profiles by following
a simple contract specified in the README file [see Addi-
tional file 1]. In the execution of the program, a set of ref-
erence profiles are first loaded to memory and compared
to all the query gene signatures to calculate the related
connection scores and p-values, the memory is then
released and the program proceeds to load another set of
reference profiles from disk. This memory management
scheme enables the program to handle an anticipated
increasing number of reference profiles at a moderate cost
of speed. If all the available reference profiles were resid-
ing in memory, the number of reference profiles allowed
would soon be limited.
Results
The core database
The Broad Institute released Build 02 of their Connectivity
Map http://www.broad.mit.edu/cmap/ with an expanded
dataset over the 01 version with more compounds uti-
lized. Using these data we constructed 6100 reference
gene-expression profiles using the method described in
our previous report [2]. In brief the genes were primarily
sorted by the absolute value of log-ratios in descending
order, so that the most differentially expressed gene has
the highest rank. Thus sscMap comes with a default core
database of 6100 reference profiles, each characterizes a
treatment instance as described in [1]. This core database
covers the treatment instances of over 1000 small-mole-
cule compounds applied to 5 human cell lines. So the pri-
mary utility of sscMap is for users who want to compare
their gene signatures to the reference profiles based on the
Connectivity Map 02 dataset. The benefits of the method
implemented in this application include a more princi-
pled statistical procedure [6-8], effective safeguards
against false connections, and an increased sensitivity.
The sscMap program can be run in two execution modes:
as a command line program, or as a GUI (Graphical User
Interface) application. In the simple command line mode
using the built-in core database users can simply put their
gene signature files into the queries folder and run the
application. Detailed instructions and guided tours on
how to run the program in GUI mode can be found in the
accompanying README file [see Additional file 1]. For
more advanced application the database can be added to
at the users discretion as described below.
Extensibility: Building custom extensions
Users who want a greater capacity for comparison than the
built-in database can build up their own custom reference
profiles and apply the same scoring scheme and statistical
testing procedures introduced in [2]. This section briefly
describes how users can customize the application.
A plain text file, parameters.ini for the command line
mode, or for-gui/default-parameters.ini for the GUI mode,
sets the key parameters used by the program, e.g., where
to find the ref-files (reference gene-expression profiles). In
the default settings, we specified reffiles as the default
folder, where the 6100 reference profiles are stored. It is
possible to supplement them by simply putting more sim-
ilarly built ref-files into the default folder. Users can also
create a new directory, for example, custom-reffiles, and put
all the custom ref-files there, and then point the reference
profiles folder to that directory, either by editing the
parameters.ini file for the command line, or by browsing to
the custom directory in the GUI mode. As an example, we
have included with sscMap a folder custom-example, which
contains all the key components of a customized exten-
sion to the application. Following the example provided
users should be able to build their own extension. A more
detailed description of the general contracts for adding a
custom collection of reference profiles to sscMap can be
found in the README file [see Additional file 1] accom-
panying the software.
Flexibility: Treatment set definition
The sscMap software downloads with a default ref-files
folder containing 6100 pre-built reference expression pro-
files. An example ref-file is azathioprine_0.1
mM_MCF7_338.ref.tab, which characterizes the biological
state of MCF7 cells treated with 0.1 mM azathioprine. The
name of a typical ref-file is divided by the underscore char-
acter _, the default field separator, into 4 fields: drug
name, dose, cell type, and instance ID, respectively. The
program allows users to specify which field(s) to use for
defining a "treatment set" (A term we use interchangeably
with "reference set", or simply ref-set elsewhere). Our pre-
ferred choice for the default ref-files is to use the 3 fields:
drug name (field 0), dose (field 1), and cell type (field 2)
together to define a treatment set, meaning that only ref-
erence profiles with the same drug, same dose, and same
cell type should be regarded as forming a set in the set-
level analysis. The original Connectivity Map uses only
the drug name to define a treatment set, disregarding pos-
sible difference in dose and cell type. This tends to average
out the distinct characteristics attributable to the cell typePage 2 of 4
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insignificant or their interpretation difficult. We described
in the discussion section of [2] why it was preferable to
use 3 fields to define a treatment set. However, the pro-
gram does not force users to follow this preference. With
sscMap, users can choose whatever field(s) they feel
appropriate to define a set. One extreme case is to use all
the fields of a ref-file name, and consequently each treat-
ment set will have only one treatment instance (such a
treatment set is called a singleton set) and this reduces to
the instance-level analysis.
In the custom-example folder, the custom ref-files names
are divided by a custom filed separator, --, ie, two hyphen
characters, into 4 fields: drug name, dose, tissue type, and
time point, as in Drug2––LowDose––Tissue3––
Day11.ref.tab. Treatment sets are defined using two fields,
Drug name (field 0) and Tissue type (field 2) in this case.
Thus the example here demonstrates the flexibility offered
by the application: users have the freedom to choose their
own field separator, the number of fields, and which
fields to define a treatment set.
Example 1: Using the default core collection of ref-files
As an example of querying the default core database, we
used the five gene signatures previously reported in [2].
Note that this default core database contains 6100 refer-
ence gene-expression profiles, which is a much-expanded
collection as compared to 453 in [2]. The connection
scores and p-values for the Estrogen gene signature are
shown here in Figure 1 in graphical view. The detailed tab-
ulated results can be found as a tab file (Estrogen.sig.ssc-
map.tab) in the results folder within the downloaded
software.
Example 2: Using a custom collection of ref-files
In the folder custom-example we provided a small collec-
tion of 18 custom reference profiles, constructed using
Affymetrix RAT230_2 microarray data. We then queried
this small database of custom reference profiles using 2
specially prepared gene signatures based on mouse cDNA
microarray data. To query the rat reference profiles using
mouse gene signatures, we first converted the gene IDs on
the mouse array to the Affymetrix Rat230_2 probeset IDs,
using the annotation file provided by Affymetrix. The bio-
logical contexts of these reference profiles and gene signa-
tures in this example are not directly relevant, as we are
Results for the Estrogen gene signatureFig re 1
Results for the Estrogen gene signature. A screenshot of the sscMap program displaying the volcano plot for the Estro-
gen gene signature. The x-axis is for the standardized connection score, while the y-axis is for -log10 p. The green horizontal 
line is for the pre-set threshold p-value. Any data points above that line are considered as statistically significant. In the example 
shown in this figure, the threshold p-value was set as 1/N = 1/3738.Page 3 of 4
(page number not for citation purposes)
BMC Bioinformatics 2009, 10:236 http://www.biomedcentral.com/1471-2105/10/236here simply demonstrating the possibility of extending
the sscMap software with custom reference profiles. In
Table 1, we list all the connections of the 6 reference sets,
each containing 3 individual reference profiles, to one of
the mouse gene signatures.
Conclusion
The utility of sscMap is two fold. First, it serves to make
statistically significant connections between a user-sup-
plied gene signature and the 6100 core reference profiles
based on the Broad Institute expanded dataset. Second, it
allows users to apply the scoring scheme and statistical
procedures described in [2] to custom-built reference pro-
files which can be added to the database for future refer-
encing.
Availability and requirements
Project name: sscMap
Project home page: http://purl.oclc.org/NET/sscMap
Operating system(s): Platform independent
Programming language: Java
Other requirements: Java Runtime Environment 1.6 or
later version is required to run the program.
License: None required for research and academic use
Any restrictions to use by non-academics: For commercial
use, please contact the authors
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readme. The README file of the software, which provides detailed 
instructions and guided tours for running the program.
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Table 1: The connections of the rat reference profiles with a mouse gene signature
ref-set set size set score set pvalue stdev of rdscores setscore/stdev
Drug2–Tissue2 3 0.0036 0.9716 0.0908 0.0394
Drug1–Tissue1 3 0.1553 0.0468 0.0790 1.9651
Drug1–Tissue2 3 0.0167 0.8638 0.0983 0.1694
Drug1–Tissue3 3 0.0221 0.7816 0.0799 0.2767
Drug2–Tissue1 3 -0.1934 0.0574 0.1020 -1.8953
Drug2–Tissue3 3 0.0648 0.3674 0.0709 0.9143Page 4 of 4
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